EPIDEMIOLOGICAL INDICATORS OF MULTIPLE SCLEROSIS IN THE CITY OF BAKU

Introduction. Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, which ranks the second place according to the frequency of disability among young people with neurological disorders. At present, there has not been made any large-scale epidemiological study on the epidemiology of MS in Azerbaijan. The purpose of the research is to study the prevalence and incidence of MS among residents of Baku city. Material and Methods. The material of the research was 559 patients. There were 392 (70%) females and 167 (30%) males. The final diagnosis of MS was made according to the 2010 McDonald criteria. Results. The prevalence of MS was 10.2 patients per 100000 people in 2013. From 2014 to 2019, there was an increase in prevalence from 12.3 to 23.3/100000. The prevalence of MS among men and women was statistically significantly different by statics and came to 2.3:1. The incidence of MS from 2013 to 2020 remained relatively stable at the rate of 2.1-2.9 per 100,000 people. The incidence rate of women in the period of 2013-2019 increased over the years from 2.7 to 3.7, as to men it had a downward trend from 2.1 to 0.9 per 100,000 people. The incidence of MS had the highest representation in the age groups of 20-29 and 30- 39. Conclusion. According to the prevalence of MS, the city of Baku corresponds to the geographic zones of medium risk. The increase in the prevalence of MS from 2013 to 2019 with women occurs at a higher rate than with men. The incidence rate of MS in Baku remains relatively stable at 2.1-2.9 patients per 100,000 people. The incidence of MS in the number of people aged from 20 to 40 prevails in all the years studied.